Skip to main
ALGN

Align Technology (ALGN) Stock Forecast & Price Target

Align Technology (ALGN) Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 25%
Buy 50%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Align Technology is positioned well in a large and under-penetrated market with its dominant market share and a strong network of trained providers. The company's recent results have shown impressive breadth across geographies and channels, with strong demand for both its Invisalign clear aligners and iTero intraoral scanners. The company's management has set reasonable guidance for 2026, with expectations for continued growth and improved margins, giving investors increasing confidence in the stock's performance.

Bears say

Align Technology is heavily reliant on its Invisalign product, which controls over 90% of the clear aligner market. However, with an estimated 10% of all orthodontic cases treated by Invisalign in 2022 and a total of 14 million patients treated since launch, it is facing a saturated market. Additionally, the company's other product, iTero intraoral scanners, only capture a little over half of digital scans and face increasing competition from other digital scanning options, making it harder for them to maintain market dominance and sustain long-term growth.

Align Technology (ALGN) has been analyzed by 12 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 50% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Align Technology and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Align Technology (ALGN) Forecast

Analysts have given Align Technology (ALGN) a Buy based on their latest research and market trends.

According to 12 analysts, Align Technology (ALGN) has a Buy consensus rating as of Aug 4, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $202.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $202.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Align Technology (ALGN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.